Karen Smith
Patrimonio netto: 216 867 $ in data 31/08/2026
Patrimonio netto: 216 867 $ in data 31/08/2026
La dott.ssa Karen L. Smith è direttore medico di Emergent BioSolutions, Inc., amministratore indipendente di Antares Pharma, Inc., amministratore indipendente di Sangamo Therapeutics, Inc. e amministratore indipendente di Acceleron Pharma, Inc. Fa parte del consiglio di amministrazione di Antares Pharma, Inc., Sangamo Therapeutics, Inc. e Acceleron Pharma, Inc. La dott.ssa Smith è stata precedentemente impiegata come presidente e amministratore delegato di Medeor Therapeutics, Inc., amministratore delegato di Eliminate Cancer, Inc., amministratore e vicepresidente di Celator Pharmaceuticals, Inc, un amministratore non esecutivo di Forward Pharma A/S, un Chief Medical Officer & EVP-Research & Development di Jazz Pharmaceuticals Plc, un SVP-Global Medical Affairs & Head-Dermatology di Allergan, Inc., un Head-External Medical Relations di AstraZeneca LP, un Head-US Clinical Operations di Bristol Myers Squibb Co. e un Chief Executive Officer di Boron Molecular Ltd. È stata anche membro del consiglio di amministrazione di Sucampo Pharmaceuticals, Inc. Ha conseguito la laurea presso la Curtin University of Technology, una laurea presso l'Università di Salford, un MBA presso l'Università del New England (Australia), un dottorato presso l'Università di Warwick e un dottorato presso la University of Western Australia.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/04/2025 | 12.672 ( 0,01% ) | 204 146 $ | 31/08/2026 | |
| 20/04/2026 | 77.100 ( 0,02% ) | 12 722 $ | 31/08/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
| 24/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/06/2018 |
| EMYRIA LIMITED | Direttore/Membro del Consiglio | 29/11/2021 |
| SKYE BIOSCIENCE, INC. | Direttore/Membro del Consiglio | 02/07/2024 |
| CONTEXT THERAPEUTICS INC. | Direttore/Membro del Consiglio | 04/09/2024 |
| Società | Posizione | Fine |
|---|---|---|
| TOUE BIOPAR | Direttore/Membro del Consiglio | 01/10/2023 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
| QUINCE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
| ANTARES PHARMA, INC. | Direttore/Membro del Consiglio | 24/05/2022 |
| EMERGENT BIOSOLUTIONS INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2021 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 31 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Celator Pharmaceuticals, Inc.
Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Salford
University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boron Molecular Ltd.
Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Produces and distributes chemicals and compounds to the pharmaceutical and biotechnology industries | Process Industries |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New England (Australia)
University of New England (Australia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology, inflammatory diseases & biodefense drugs | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Talaris Therapeutics, Inc.
Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Curtin University of Technology
Curtin University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emyria Ltd.
Emyria Ltd. Packaged SoftwareTechnology Services Develops patient-centric care model technology | Technology Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Eliminate Cancer, Inc. | |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale